Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
25%(2 trials)

Phase Distribution

Ph phase_2
3
27%
Ph phase_3
6
55%
Ph not_applicable
1
9%

Phase Distribution

0

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
6(60.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(8)
Other(3)

Detailed Status

Completed8
unknown3

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (30.0%)
Phase 36 (60.0%)
N/A1 (10.0%)

Trials by Status

completed873%
unknown327%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_2

Adjunctive Granisetron Therapy in Patients With Sepsis or Septic Shock

NCT03924518
unknownphase_2

Role of Granisetron in Preventing Hypotension After Spinal Anesthesia With Levobupivacaine in Rheumatic Patients Undergoing Elective Cesarean Section

NCT05314257
completed

Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section

NCT03318536
completednot_applicable

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

NCT00293384
completedphase_3

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

NCT00475085
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT03924518Phase 2

Adjunctive Granisetron Therapy in Patients With Sepsis or Septic Shock

Completed
NCT05314257Phase 2

Role of Granisetron in Preventing Hypotension After Spinal Anesthesia With Levobupivacaine in Rheumatic Patients Undergoing Elective Cesarean Section

Unknown
NCT03318536

Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section

Completed
NCT00293384Not Applicable

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Completed
NCT00475085Phase 3

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

Completed
NCT00003817Phase 2

Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy

Completed
NCT00020657Phase 3

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

Completed
NCT00005024Phase 3

Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease

Unknown
NCT00004219Phase 3

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

Unknown
NCT00003213Phase 3

Drugs to Reduce the Side Effects of Chemotherapy

Completed
NCT00359567Phase 3

Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11